HKU and SIIDB Collaborate on Drug Development for Infectious Diseases
The Department of Microbiology at the University of Hong Kong (HKU) and the Shanghai Institute...
Deals
XtalPi Inc. and CK Life Sciences Expand Partnership to Develop AI-Powered Cancer Diagnostics
Sino-US artificial intelligence (AI) firm XtalPi (QuantumPharm, HKG: 2228) has announced a strategic partnership agreement...
Bayer Extends Collaboration with Broad Institute to 2028 for Oncology Drug Targets and Therapies
Germany’s Bayer (NYSE: ETR) has announced the extension of its 2013 collaboration agreement with the...
AbbVie Secures Option Agreement with Aldeyra Therapeutics for RASP Modulator Reproxalap
AbbVie (NYSE: ABBV) has entered into an option agreement with Aldeyra Therapeutics (NASDAQ: ALDX), a...
Sanofi Regains Exclusive Rights to Rezurock in China, Terminating Agreement with BioNova and BK Pharmaceuticals
BioNova Pharmaceuticals, a Shanghai-based oncology-focused biopharmaceutical company founded in 2018, and Sanofi (NASDAQ: SNY), a...
AstraZeneca Partners with Cellectis for Next-Generation Cell and Gene Therapies
UK pharmaceutical giant AstraZeneca (AZ; NASDAQ: AZN) has announced a strategic partnership with Cellectis (EPA:...
We-Linking Secures Angel Financing for Implantable Brain Computer Interface Development
Shenzhen-based company We-Linking, a specialist in implantable brain computer interfaces (BCI), has reportedly raised tens...
3SBio Inc. and CStone Pharmaceuticals Enter Strategic Partnership for Nofazinlimab
China-based 3SBio Inc., (HKG: 1530) has announced a strategic partnership and exclusive licensing agreement with...
Resolian Expands Global Reach with Acquisition of China-Based Denali Medpharma
US-based bioanalytical contract research organization (CRO) Resolian has announced the acquisition of China-based CRO Denali...
Shanghai’s Argo Biopharma Raises USD 41 Million in Series A+ Financing Round
Shanghai-based siRNA drug developer Argo Biopharma has reportedly secured RMB 300 million (USD 41 million)...
ImmuXell Biotech Secures Over RMB 100 Million in Series A Funding for Cell Therapy Development
ImmuXell Biotech Co., Ltd, a Shanghai-based cell therapy developer, has reportedly secured over RMB 100...
AnHeart Therapeutics Signs Exclusive License Deal with Nippon Kayaku for Taletrectinib
China-based AnHeart Therapeutics has announced the signing of an exclusive license deal with Japan-based biopharma...
BioLineRx Licenses Multiple Myeloma Drug Motixafortide to Guangzhou Gloria Biosciences
Israel’s BioLineRx has entered into a licensing agreement with Guangzhou Gloria Biosciences Co., Ltd., based...
Triastek Partners with BASF to Advance 3D Printing Materials for Pharmaceuticals
China-based Triastek Inc., a leader in pharmaceutical-focused 3D printing, has announced a strategic partnership with...
Novo Nordisk Acquires Global License for Vect-Horus Molecular Cargo Delivery Platform
Novo Nordisk (NYSE: NVO), a leading pharmaceutical company based in Denmark, has obtained an exclusive...
Merck KGaA and Jiangsu Hengrui Ink Strategic Collaboration Deal for Next-Gen PARP1 Inhibitor
Germany-based Merck KGaA (NYSE: MRK) has announced the signing of a strategic collaboration deal with...
Danyang Huichuang Secures Over USD 13.7 Million in Series B Funding for fNIRS Development
Danyang Huichuang Medical Equipment Co., Ltd, a China-based specialist in functional near-infrared spectroscopy (fNIRS), has...
BMS and Karyopharm Partner to Evaluate Mezigdomide and Xpovio in Relapsed/Refractory Multiple Myeloma
Bristol Myers Squibb (BMS; NYSE: BMY) has entered into a collaboration and supply agreement with...
Shanghai Henlius Biotech and Intas Pharmaceuticals Ink New Licensing Deal for PD-1 mAb
China’s Shanghai Henlius Biotech Inc., (HKG: 2696) has announced a new licensing agreement with India-based...
Strategic Alliance Formed by uBriGene, Fraserna, and Virogin for Cell and Gene Therapy Services
In a significant move to bolster the cell and gene therapy (CGT) sector, China-based biotechnology...